Imatron Inc. shares rose 67% after the company reported that scientific papers describe how an Imatron technology can help predict heart disease.
Imatron's Electron Beam Ultrafast CT technology is used to detect calcium buildup in coronary arteries.
Papers presented at a meeting of cardiologists in Atlanta included evidence that a high degree of calcification in patients with no other known symptoms is associated with future occurrences of coronary artery disease and heart attacks.
The South San Francisco, Calif., company's shares closed Friday at $1.56 a share, up 63 cents, on the Nasdaq Stock Market.
